Abstract
Maintenance Treatment with Guadecitabine (SGI-110) in High Risk MDS and AML Patients after Allogeneic Stem Cell Transplantation
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have